Implementing Stepped Financial and Legal Navigation to Mitigate Financial Toxicity in Adolescent and Young Adult Cancer Patients Oncology Financial and Legal Navigation (OFLN)
OFLN
1 other identifier
interventional
294
1 country
1
Brief Summary
The overall objective of this study is to test the effectiveness and implementability of stepped OFLN in a noninferiority randomized controlled trial (RCT) using a hybrid type 1 (effectiveness-implementation) design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2027
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedStudy Start
First participant enrolled
February 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
Study Completion
Last participant's last visit for all outcomes
June 1, 2031
September 30, 2026
September 1, 2026
3.8 years
September 24, 2026
September 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Financial Toxicity: Psychological Response
Financial toxicity (psychological response) will be measured using the 11-item Comprehensive Score for Financial Toxicity (COST) that measures emotional aspects of financial hardship (financial toxicity) among cancer patients. Each item is scored on a 5-point ordinal scale ranging from 0='Not at all' to 4='Very much. Lower values indicate greater financial toxicity.
From baseline to 12-, 30- (primary), and 48-weeks; and also measured every 6 weeks as screener
Implementation Outcomes
Intervention acceptability, appropriateness and feasibility will be measured using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM) with 12 items total, 3 subscales. Higher scores indicate greater intervention acceptability, appropriateness and feasibility.
Measured at 30-weeks and 48-weeks
Secondary Outcomes (8)
Change in Financial Toxicity: Material Burden
Baseline to 12-, 30-, and 48-weeks
Change in Financial Toxicity: Coping Burden
Baseline to 12-, 30- and 48-weeks
Change in Cost-related Health Literacy
From baseline to 12-, 30-, and 48-weeks
Change in Participant Quality of Life
Baseline to 12-, 30-, and 48-weeks.
Change in Participant Quality of Life (Anxiety)
Baseline to 12-, 30- and 48-weeks
- +3 more secondary outcomes
Study Arms (2)
OFLN Stepped Arm
EXPERIMENTALOnce randomized to the stepped OFLN intervention arm, patients with a lower financial toxicity at baseline will be assigned to the low-intensity OFLN and patients with high financial toxicity will be assigned to the high-intensity OFLN.
OFLN Standard
ACTIVE COMPARATORPatients randomized to the standard OFLN arm will receive standard navigation services which includes access to a virtual, navigator-led program.
Interventions
Patients' baseline needs will be reviewed by Triage Cancer navigators who will build and personalize their self-managed navigation program and mail introductory packets and resource materials to patient. Pt will receive an email link to access their personalized program. The program will include a customized package of Triage Cancer's educational resources (e.g., webinars, quick guides, interactive tools. Patients will have roughly 4 weeks to complete their program, lasting \~4 hours, and any self-directed activities. Completion verification and engagement tracking questions are included in weekly check-in surveys to monitor progress. Following each 6-week screening, participants whose FT scores remain stable or improve will continue to receive an email with resources customized to newly identified needs until 30 weeks. Patients whose FT worsens and who meet criteria for stepping up following screenings (within the 30-week period) will be stepped into the high intensity arm.
Once randomized in the standard OFLN arm, patients will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect patients with appropriate resources. Triage Cancer navigators will meet with all enrolled patients for a minimum of 6 phone/videocall appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following FT screenings, and as needed. All patient will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.
Once enrolled in the high-intensity OFLN arm, patients will be contacted by Triage Cancer navigators via email to schedule an initial phone consultation to review needs and collect pertinent information on insurance and employment, income, billing and other details to help connect patients with appropriate resources. Triage Cancer navigators will meet with all enrolled patients for a minimum of 6 phone/videocall appointments starting with an initial consultation at baseline and follow-up appointments every 6 weeks following FT screenings, and as needed. All patient will receive navigation services for 30 weeks. Additional intensive legal services (i.e., legal counseling or representation) that require a jurisdiction-specific licensed lawyers will be provided by the research team's supervising attorney.
Eligibility Criteria
You may qualify if:
- Newly diagnosed with cancer within the past 12 months
- Able to read and speak English or Spanish
- Actively receiving healthcare at the University of Louisville
You may not qualify if:
- Cognitive impairments that would interfere with participation
- Unable to read and speak English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institutes of Health (NIH)collaborator
- James Graham Brown Cancer Centercollaborator
- University of Louisvillelead
Study Sites (1)
University of Louisville-Brown Cancer Center
Louisville, Kentucky, 40202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean Edward, PhD, RN, FAAN
University of Louisville-Brown Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Associate Dean for Faculty Development and Mentoring School of Nursing; Deputy Director of Nursing Research, Brown Cancer Center
Study Record Dates
First Submitted
September 24, 2026
First Posted
September 30, 2026
Study Start (Estimated)
February 1, 2027
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
June 1, 2031
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share